Phosphodiesterase-5 inhibitors and their analogues as adulterants of herbal and food products: analysis of the Malaysian market, 2014–16

References

• Bell AS, Brown D, Terrett NK, inventers; Pfizer Research and Development Company, assignee. 1992. Pyralozopyrimidone antianginal agents. Patent EP0463756 A1. ​​
   Google Scholar
• Bell AS, Terrett NK, inventers; Pfizer Research and Development Company, assignee. 1993. Pyrazolopyrimidone antianginal agents. Pfizer Research and Development Company. Patent EP0526004 B1.
   Google Scholar
• Campbell N, Clark JP, Stecher VJ, Thomas JW, Callanan AC, Donnelly BF, Goldstein I, Kaminetsky JC. 2013. Adulteration of purported herbal and natural sexual performance enhancement dietary supplements with synthetic phosphodiesterase type 5 inhibitors. J Sex Med. 10:1842–1849.
   PubMed Web of Science ®Google Scholar
• Damiano F, Silva C, Gregori A, Vacondio F, Mor M, Menozzi M, Di Giorgio D. 2014. Analysis of illicit dietary supplements sold in the italian market: identification of a sildenafil thioderivative as adulterant using UPLC-TOF/MS and GC/MS. Sci Justice. 54:228–237.
   PubMed Web of Science ®Google Scholar
• ElAgouri G, ElAmrawy F, ElYazbi A, Eshra A, Nounou MI. 2015. Male enhancement nutraceuticals in the middle east market: claim, pharmaceutical quality and safety assessments. Int J Pharm. 492:109–119.
   PubMed Web of Science ®Google Scholar
• Gilard V, Balayssac S, Tinaugus A, Martins N, Martino R, Malet-Martino M. 2015. Detection, identification and quantification by 1h nmr of adulterants in 150 herbal dietary supplements marketed for improving sexual performance. J Pharm Biomed Anal. 102:476–493.
   PubMed Web of Science ®Google Scholar
• Jeong JH, Lee JH, Kim HJ, Park HJ, Hwang IS, Han KM, Yoon CY, Cho S, Kim WS. 2016. LC-ESI-MS/MS analysis of phosphodiesterase-5 inhibitors and their analogues in foods and dietary supplements in korea. Food Addit Contam B. 9:1–8.
   PubMed Web of Science ®Google Scholar
• Kim JH, Kim Y, Choi K, Kim DH, Nam G, Seo JH, inventors. 2002. Novel pyrazolopyrimidinethione derivatives, preparation methods thereof and their use as therapeutics for erectile dysfunction. Patent WO 02/102802 A1.
   Google Scholar
• Kumasaka K, Kawahara N, Doi KTK, Goda Y. 2008. Determination of (R)-xanthoanthrafil, a phosphodiesterase-5 inhibitor, in a dietary supplement promoted for sexual enhancement. Chem Pharm Bull. 56:227–230.
   PubMed Web of Science ®Google Scholar
• Lanzarotta A, Crowe JB, Witkowski M, Gamble BM. 2012. A multidisciplinary approach for the analysis of an adulterated dietary supplement where the active pharmaceutical ingredient was embedded in the capsule shell. J Pharm Biomed Anal. 67–68:22–27.
   PubMed Web of Science ®Google Scholar
• Lebel P, Gagnon J, Furtos A, Waldron KC. 2014. A rapid, quantitative liquid chromatography-mass spectrometry screening method for 71 active and 11 natural erectile dysfunction ingredients present in potentially adulterated or counterfeit products. J Chromatogr A. 1343:143–151.
   PubMed Web of Science ®Google Scholar
• Lee ES, Lee JH, Han KM, Kim JW, Hwang IS, Cho S, Han SY, Kim J. 2013. Simultaneous determination of 38 phosphodiestrase-5 inhibitors in illicit erectile dysfunction products by liquid chromatography-electrospray ionization-tandem mass spectrometry. J Pharm Biomed Anal. 83:171–178.
   PubMed Web of Science ®Google Scholar
• Lee HM, Lee BJ. 2011. A novel approach to simultaneous screening and confirmation of regulated pharmaceutical compounds in dietary supplements by LC/MS/MS with an information-dependent acquisition method. Food Addit Contam A. 28:396–407.
   Web of Science ®Google Scholar
• Lee S, Ji D, Park M, Chung KH. 2015. Development of a comprehensive spectral library of sildenafil and related active analogues using LC-QTOF-MS and its application for screening counterfeit pharmaceuticals. Forensic Sci Int. 257:182–188.
   PubMed Web of Science ®Google Scholar
• National Pharmaceutical Regulatory Agency. 2015. Drug registration guidance document. 1st ed. Malaysia: Petaling Jaya.
   Google Scholar
• Patel DN, Li L, Kee CL, Ge X, Low MY, Koh HL. 2014. Screening of synthetic PDE-5 inhibitors and their analogues as adulterants: analytical techniques and challenges. J Pharm Biomed Anal. 87:176–190.
   PubMed Web of Science ®Google Scholar
• Pharmaceutical Services Division. 2010. Warning to medicinal or health food manufacturers that adulterate their products with scheduled poisons. Available from: http://www.pharmacy.gov.my/v2/en/news/16-aug-2010/warning-medicinal-or-health-food-manufacturers-adulterate-their-products-scheduled-poisons.html
   Google Scholar
• Reeuwijk NM, Venhuis BJ, de Kaste D, Hoogenboom LA, Rietjens IM, Martena MJ. 2013. Sildenafil and analogous phosphodiesterase type 5 (PDE-5) inhibitors in herbal food supplements sampled on the dutch market. Food Addit Contam A. 30:2027–2034.
   PubMed Web of Science ®Google Scholar
• Rocha T, Amaral JS, Oliveira MBPP. 2016. Adulteration of dietary supplements by the illegal addition of synthetic drugs: A review. Compr Rev Food Sci Food Saf. 15:43–62.
   PubMed Web of Science ®Google Scholar
• Singh S, Prasad B, Savaliya A, Shah R, Gohil V, Kaur A. 2009. Strategies for characterizing sildenafil, vardenafil, tadalafil and their analogues in herbal dietary supplements, and detecting counterfeit products containing these drugs. Trends Anal Chem. 28:13–28.
   Web of Science ®Google Scholar
• Steers WD. 2002. Pharmacologic treatment of erectile dysfunction. Rev Urol. 4:S17–S25.
   PubMedGoogle Scholar
• USFDA. 2012. FDA approves stendra for erectile dysfunction. Silver Spring (MD): U.S. Food and Drug Administration. Available from: http://www.fda.gov/newsevents/newsroom/pressannouncements/ucm302140.htm
   Google Scholar
• Vaclavik L, Krynitsky AJ, Rader JI. 2014. Mass spectrometric analysis of pharmaceutical adulterants in products labeled as botanical dietary supplements or herbal remedies: A review. Anal Bioanal Chem. 406:6767–6790.
   PubMed Web of Science ®Google Scholar
• Venhuis BJ, de Kaste D. 2012. Towards a decade of detecting new analogues of sildenafil, tadalafil and vardenafil in food supplements: A history, analytical aspects and health risks. J Pharm Biomed Anal. 69:196–208.
   PubMed Web of Science ®Google Scholar
• Zou P, Hou P, Oh SS, Ge X, Bloodworth BC, Low MY, Koh HL. 2008. Identification of benzamidenafil, a new class of phosphodiesterase-5 inhibitor, as an adulterant in a dietary supplement. J Pharm Biomed Anal. 47:255–259.
   PubMed Web of Science ®Google Scholar
• Zou P, Oh SS, Hou P, Low MY, Koh HL. 2006. Simultaneous determination of synthetic phosphodiesterase-5 inhibitors found in a dietary supplement and pre-mixed bulk powders for dietary supplements using high-performance liquid chromatography with diode array detection and liquid chromatography-electrospray ionization tandem mass spectrometry. J Chromatogr A. 1104:113–122.
   PubMed Web of Science ®Google Scholar